DWTX
DWTX
NASDAQ · Biotechnology

Dogwood Therapeutics Inc

$1.98
-0.10 (-4.81%)
Financial Highlights (FY 2025)
Revenue
12.10M
Net Income
3.15M
Gross Margin
44.1%
Profit Margin
26.0%
Rev Growth
+0.7%
D/E Ratio
0.93
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 44.1% 44.1% 44.1%
Operating Margin 27.6% 24.1% 25.1%
Profit Margin 26.0% 20.2% 22.8%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.10M 11.96M 10.98M
Gross Profit 5.33M 5.27M 4.84M
Operating Income 3.34M 2.88M 2.76M
Net Income 3.15M 2.42M 2.50M
Gross Margin 44.1% 44.1% 44.1%
Operating Margin 27.6% 24.1% 25.1%
Profit Margin 26.0% 20.2% 22.8%
Rev Growth +0.7% +19.7% +24.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 49.65M 44.85M 51.81M
Total Equity 53.46M 61.84M 55.56M
D/E Ratio 0.93 0.73 0.93
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 4.53M 4.37M 3.74M
Free Cash Flow 1.56M 1.43M 1.67M